z-logo
open-access-imgOpen Access
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
Author(s) -
Pasquale Pisapia,
Danilo Rocco,
Francesco Pepe,
Caterina De Luca,
Ciro Battiloro,
Riccardo Smeraglio,
Miriam Cieri,
Claudio Bellevicine,
Giancarlo Troncone,
Umberto Malapelle
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.09.13
Subject(s) - mechanism (biology) , osimertinib , exon , mutation , genetics , cancer research , biology , medicine , gene , physics , kras , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom